NEW YORK (GenomeWeb) – Swiss clinical genomics analysis firm Sophia Genetics announced today it has obtained CE-IVD marking for a solution to detect copy number variations in BRCA1 and BRCA2 genes. 

The company has developed an algorithm that directly detects CNVs from next-generation sequencing data. Using the firm's data-driven medicine platform, clinicians can detect all variant types for BRCA1/2 genes in one experiment, it said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.